J
Jawaid Akhtar
Researcher at National University of Science and Technology
Publications - 19
Citations - 713
Jawaid Akhtar is an academic researcher from National University of Science and Technology. The author has contributed to research in topics: Docking (molecular) & Benzimidazole. The author has an hindex of 9, co-authored 19 publications receiving 395 citations. Previous affiliations of Jawaid Akhtar include Jamia Hamdard & Hamdard University.
Papers
More filters
Journal ArticleDOI
Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities.
TL;DR: The present review article offers a detailed account of the design strategies employed for the synthesis of nitrogen-containing anticancer agents and a systematic analysis of the structure-activity relationship among the series.
Journal ArticleDOI
Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors
Jawaid Akhtar,Anees A. Siddiqui,Ahsan Ahmed Khan,Zulphikar Ali,Rikeshwer Prasad Dewangan,Santosh Pasha,M. Shahar Yar +6 more
TL;DR: The synthesis of benzimidazole linked oxadiazole derivatives designed as potential EGFR and erbB2 receptor inhibitors with anticancer and apoptotic activity were studied and compounds 7a and 7n showed normal architecture of myofibrils in cardiomyopathy study whereas only compound 7a showed nearly equal biochemical parameters when compared to control.
Journal ArticleDOI
Current perspectives on quinazolines with potent biological activities: A review
TL;DR: Quinazoline is a heterocyclic compound having biological activities as discussed by the authors, it is aromatic in nature having bicyclic structure containing benzene ring and pyrimidine ring.
Journal ArticleDOI
Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship
TL;DR: Design strategies for the synthesis of isatin containing heterocyclic through their different approaches have been represented and structural insights and important account of structure-activity relationships and docking studies of isarin derivatives for the potent pharmacological profile are provided.
Journal ArticleDOI
DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective.
Ankita Pathak,Ankit Rohilla,Tanya Gupta,Jawaid Akhtar,Rafi Haider,Kalicharan Sharma,Kashif Haider,M. Shahar Yar +7 more
TL;DR: This review focuses on the current status of the research and contributions in the development of DYRK1A inhibitors, a potential target for prevention of neuro-degeneration and hence Alzheimer.